Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/wh78nb/biochips_global) has announced the addition of the "Biochips - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others.
The report further analyzes the market by the following Applications: Research, Diagnostics, and Others.
Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 79 companies including many key and niche players such as
- Affymetrix, Inc. (US)
- Agilent Technologies, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Cepheid Inc. (US)
- Fluidigm Corporation (US)
- GE Healthcare Ltd. (UK)
- Hoffman-La-Roche Ltd. (Switzerland)
- Illumina, Inc. (US)
- Ocimum Biosolutions Ltd. (India)
- PerkinElmer, Inc. (US)
- Takara Bio, Inc. (Japan)
- Clontech Laboratories, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. INNOVATIONS IN THE BIOCHIPS INDUSTRY
3. COMPETITION
4. PRODUCT OVERVIEW
5. BIOCHIP AND MICROARRAY CONSTRUCTION
6. APPLICATIONS OF BIOCHIPS
7. PRODUCT INTRODUCTIONS
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT GLOBAL PLAYERS
10. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 79 (including Divisions/Subsidiaries 86)
- The United States (45)
- Canada (2)
- Japan (6)
- Europe (22)
- - France (2)
- - Germany (6)
- - The United Kingdom (3)
- - Spain (2)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (10)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/wh78nb/biochips_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology
